| 出版应用/物种/样本/稀释 | 参考文献 |
|---|
| Zhu G, Wang W, Chen C, Tang L, Liang Y, Zhang Z, et al. UHPLC-MS-based metabolomics and chemoinformatics study reveals the neuroprotective effect and chemical characteristic in Parkinson's disease mice after oral administration of Wen-Shen-Yang-Gan decoction. Aging (Albany NY). 2021;13:19510-19528 pubmed 出版商 |
| Reyes J, Ekmark Lewén S, Perdiki M, Klingstedt T, Hoffmann A, Wiechec E, et al. Accumulation of alpha-synuclein within the liver, potential role in the clearance of brain pathology associated with Parkinson's disease. Acta Neuropathol Commun. 2021;9:46 pubmed 出版商 |
- 免疫组化-石蜡切片; 人类; 1:50; 图 4a
| Zha J, Liu X, Zhu J, Liu S, Lu S, Xu P, et al. A scFv antibody targeting common oligomeric epitope has potential for treating several amyloidoses. Sci Rep. 2016;6:36631 pubmed 出版商 |
| Anandhan A, Nguyen N, Syal A, Dreher L, Dodson M, Zhang D, et al. NRF2 Loss Accentuates Parkinsonian Pathology and Behavioral Dysfunction in Human α-Synuclein Overexpressing Mice. Aging Dis. 2021;12:964-982 pubmed 出版商 |
| Li H, Wu S, Ma X, Li X, Cheng T, Chen Z, et al. Co-editing PINK1 and DJ-1 Genes Via Adeno-Associated Virus-Delivered CRISPR/Cas9 System in Adult Monkey Brain Elicits Classical Parkinsonian Phenotype. Neurosci Bull. 2021;: pubmed 出版商 |
| Moors T, Maat C, Niedieker D, Mona D, PETERSEN D, Timmermans Huisman E, et al. The subcellular arrangement of alpha-synuclein proteoforms in the Parkinson's disease brain as revealed by multicolor STED microscopy. Acta Neuropathol. 2021;142:423-448 pubmed 出版商 |
| Van Den Berge N, Ferreira N, Gram H, Mikkelsen T, Alstrup A, Casadei N, et al. Evidence for bidirectional and trans-synaptic parasympathetic and sympathetic propagation of alpha-synuclein in rats. Acta Neuropathol. 2019;: pubmed 出版商 |
| McGlinchey R, Lacy S, Huffer K, Tayebi N, Sidransky E, Lee J. C-terminal α-synuclein truncations are linked to cysteine cathepsin activity in Parkinson's disease. J Biol Chem. 2019;294:9973-9984 pubmed 出版商 |
| Gerson J, Farmer K, Henson N, Castillo Carranza D, Carretero Murillo M, Sengupta U, et al. Tau oligomers mediate α-synuclein toxicity and can be targeted by immunotherapy. Mol Neurodegener. 2018;13:13 pubmed 出版商 |
| Svarcbahs R, Julku U, Norrbacka S, Myöhänen T. Removal of prolyl oligopeptidase reduces alpha-synuclein toxicity in cells and in vivo. Sci Rep. 2018;8:1552 pubmed 出版商 |
| Henderson Smith A, Chow D, Meechoovet B, Aziz M, Jacobson S, Shill H, et al. SMG1 identified as a regulator of Parkinson's disease-associated alpha-synuclein through siRNA screening. PLoS ONE. 2013;8:e77711 pubmed 出版商 |
